On Recensoring for Censored Paired Data - JSTOR,https://www.jstor.org/stable/2290703
[PDF] critical considerations when applying statistical methods to adjust for,https://eprints.whiterose.ac.uk/120076/7/ispor_boston_abstract.pdf
[PDF] Should re-censoring be applied when estim - ScienceOpen,https://www.scienceopen.com/document_file/1f1e581b-00ba-4b73-9525-3a49e1349e43/PubMedCentral/1f1e581b-00ba-4b73-9525-3a49e1349e43.pdf
[PDF] Two-stage estimation to adjust for treatment switching in randomised ...,https://d-nb.info/1184196885/34
strbee: Randomization-based Efficacy Estimator - SAGE Journals,https://journals.sagepub.com/doi/pdf/10.1177/1536867X0200200203
[PDF] What decision makers need to understand about treatment switching,https://www.ispor.org/docs/default-source/presentations/92114pdf.pdf%3Fsfvrsn%3D573862ec_0
[PDF] On Recensoring for Censored Paired Data - eScholarship,https://escholarship.org/content/qt1rr8q7wb/qt1rr8q7wb.pdf
[PDF] censoring reproductive rights content_17 August 2022.docx,https://www.accessnow.org/letter-to-meta-censoring-reproductive-rights-content
[PDF] Two-stage estimation to adjust for treatment switching in randomised ...,https://bmcmedresmethodol.biomedcentral.com/track/pdf/10.1186/s12874-019-0709-9.pdf
[PDF] Teasing out the overall survival benefit with adjustment for treatment ...,https://arxiv.org/pdf/1908.00654
[PDF] CRITICAL CONSIDERATIONS WHEN ... - The University of Sheffield,https://figshare.shef.ac.uk/articles/To_re-censor_or_not_to_re-censor_that_is_the_question_Critical_considerations_when_applying_statistical_methods_to_adjust_for_treatment_switching_in_clinical_trials/11897421/files/21818760.pdf
[PDF] Dr. Sabine Lauer PhUSE 2015 - LexJansen,https://www.lexjansen.com/phuse/2015/sp/SP02_ppt.pdf
[PDF] Adjusting for Treatment Switching in RCTs - Semantic Scholar,https://pdfs.semanticscholar.org/bc50/dab0b7c591a1001aa8b84727acafce70a6f8.pdf
[PDF] Regorafenib for previously treated unresectable or metastatic ...,https://njl-admin.nihr.ac.uk/document/download/2022300
Regorafenib for previously treated unresectable or metastatic ...,https://njl-admin.nihr.ac.uk/document/download/2022309
[PDF] Adjusting Survival Time Estimates to Account for Treatment ...,https://citeseerx.ist.psu.edu/viewdoc/download%3Fdoi%3D10.1.1.895.3730%26rep%3Drep1%26type%3Dpdf
[PDF] 4.7 Appendix G: Format for Input Files,https://pubs.usgs.gov/of/2005/1081/pdf/QW-AppxG.pdf
[PDF] 3-Arm RPSFT to adjust for treatment switching in superiority trials,https://www.psiweb.org/docs/default-source/2018-psi-conference-posters/38-hannes-bucher.pdf%3Fsfvrsn%3D3f6bdedb_4
[PDF] Should re-censoring be applied when estim - UCL Discovery,https://discovery.ucl.ac.uk/10048886/1/White_0962280218780856.pdf
[PDF] NICE DSU TECHNICAL SUPPORT DOCUMENT 16,https://eclass.uoa.gr/modules/document/file.php/MED1174/Lectures/Unit%25207%2520%2528Missing%2520data%2520and%2520non-compliance%2529/TSD16_Treatment_Switching.pdf
[PDF] Recensor Past Tense - GrammarTOP.com,https://grammartop.com/recensor-past-tense/%3Fpdf%3D81199
SUPPLEMENTARY MATERIALS - JMCP,https://www.jmcp.org/pb-assets/Supplmental%2520Material/SupplementaryMaterials22086-1655223876.pdf
[PDF] Regorafenib for previously treated unresectable or metastatic ... - NICE,https://www.nice.org.uk/guidance/ta488/resources/regorafenib-for-previously-treated-unresectable-or-metastatic-gastrointestinal-stromal-tumours-pdf-82605033207493
[PDF] Package 'rpsftm',https://cran.r-project.org/web/packages/rpsftm/rpsftm.pdf
[PDF] Methods to estimate survival time after treatment switching in oncology,https://www.iqwig.de/download/14-06-27_IQWiG_im_Dialog_Norbert_Hollaender.pdf
[PDF] Adjusting overall survival for treatment switch - EFSPI,https://www.efspi.org/documents/events/archive/06_Presentation%2520Claire%2520Watkins%2520final%25202015-06-16.pdf
[PDF] Structural nested cumulative survival time models,https://researchonline.lshtm.ac.uk/4654743/1/Seaman_et_al-2019-Biometrics.pdf
More Than Obvious: Better Methods for Interpreting Nondetect Data,https://pubs.acs.org/doi/pdf/10.1021/es053368a
[PDF] Implementing the Rank-Preserving Structural Failure Time Model in ...,https://www.pharmasug.org/proceedings/2018/EP/PharmaSUG-2018-EP04.pdf
[PDF] FDA Briefing Document NDA# 216660 Drug Name: AMX0035,https://www.fda.gov/media/161378/download
PCN27 Treatment Outcomes and Healthcare Resources Utilization ...,https://www.valueinhealthjournal.com/article/S1098-3015(20)32420-7/pdf
[PDF] Nondetects and Data Analysis,https://acwi.gov/monitoring/webinars/nada-111516.pdf
Adjusting for the Confounding Effects of Treatment Switching&#x2014,https://academic.oup.com/oncolo/article-pdf/20/7/798/41870578/oncolo_20_7_798.pdf
TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING ...,https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1F90BE50752757E57B4458EE97CD0E6C/S026646231600026Xa.pdf/treatment_switching_statistical_and_decisionmaking_challenges_and_approaches.pdf
[PDF] Como se faz uma Recensão Crítica - Sapientia,https://sapientia.ualg.pt/bitstream/10400.1/5135/1/Como%2520se%2520faz%2520uma%2520Recens%25C3%25A3o%2520Cr%25C3%25ADtica.pdf
Survival with Olaparib in Metastatic Castration-Resistant Prostate ...,https://www.nejm.org/doi/pdf/10.1056/NEJMoa2022485
[PDF] A shared random effects model for censored medical costs and ...,https://deepblue.lib.umich.edu/bitstream/2027.42/49295/1/2535_ftp.pdf
[PDF] Assessing methods for dealing with treatment switching in ...,https://www.sheffield.ac.uk/media/34157/download%3Fattachment
[PDF] The Phantom Gender Difference in the College Wage Premium,https://uwpress.wisc.edu/journals/pdfs/JHR_46-3_p568_appendix.pdf
"[PDF] CUT! POLITICAL FILM CENSORSHIP IN FINLAND, 1939–1947",https://elektra.helsinki.fi/summa.pdf
